{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 495,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "The autoreload extension is already loaded. To reload it, use:\n",
      "  %reload_ext autoreload\n"
     ]
    }
   ],
   "source": [
    "%load_ext autoreload\n",
    "%autoreload 2\n",
    "import bert\n",
    "import numpy as np\n",
    "from sklearn.metrics.pairwise import cosine_similarity\n",
    "import matplotlib.pyplot as plt\n",
    "import spike_queries\n",
    "from termcolor import colored"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 455,
   "metadata": {},
   "outputs": [],
   "source": [
    "class color:\n",
    "   PURPLE = '\\033[95m'\n",
    "   CYAN = '\\033[96m'\n",
    "   DARKCYAN = '\\033[36m'\n",
    "   BLUE = '\\033[94m'\n",
    "   GREEN = '\\033[92m'\n",
    "   YELLOW = '\\033[93m'\n",
    "   RED = '\\033[91m'\n",
    "   BOLD = '\\033[1m'\n",
    "   UNDERLINE = '\\033[4m'\n",
    "   END = '\\033[0m'"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 493,
   "metadata": {},
   "outputs": [],
   "source": [
    "def load_results(fname):\n",
    "    \n",
    "    with open(fname, \"r\", encoding = \"utf-8\") as f:\n",
    "        sents = f.readlines()\n",
    "    \n",
    "    sents = [s.strip().split(\"\\t\")[-1] for s in sents]\n",
    "    original, results = sents[0], sents[1:]\n",
    "    return original, results\n",
    "\n",
    "\n",
    "def get_spike_results_arguments_representations(model, spike_results, layers):\n",
    "    \n",
    "    sents = spike_results[\"sentence_text\"].tolist()\n",
    "    arg1_idx_start = spike_results[\"arg1_first_index\"].to_numpy().astype(int)\n",
    "    arg2_idx_start = spike_results[\"arg2_first_index\"].to_numpy().astype(int)\n",
    "    arg1_idx_end = spike_results[\"arg1_last_index\"].to_numpy().astype(int)\n",
    "    arg2_idx_end = spike_results[\"arg2_last_index\"].to_numpy().astype(int)\n",
    "    \n",
    "    arg1_rep = []\n",
    "    arg2_rep = []\n",
    "    \n",
    "    for s, arg1_start, arg2_start, arg1_end, arg2_end in zip(sents, arg1_idx_start, arg2_idx_start, arg1_idx_end, arg2_idx_end):\n",
    "        #idx_to_mask = [arg1_start, arg2_start, arg1_end, arg2_end]\n",
    "        H, _, _, orig2tok = model.encode(s, layers = layers)\n",
    "\n",
    "        h1, h2 = H[orig2tok[arg1_start]:orig2tok[arg1_end] + 1], H[orig2tok[arg2_start]:orig2tok[arg2_end] + 1]\n",
    "        \n",
    "        h1 = np.mean(h1, axis = 0)\n",
    "        h2 = np.mean(h2, axis = 0)\n",
    "        \n",
    "        arg1_rep.append(h1)\n",
    "        arg2_rep.append(h2)\n",
    "        \n",
    "    arg1_mean = np.mean(arg1_rep, axis = 0)\n",
    "    arg2_mean = np.mean(arg2_rep, axis = 0)\n",
    "        \n",
    "    return arg1_mean, arg2_mean\n",
    "    \n",
    "\n",
    "def print_sentence_nicely(sentence: str, ind1, ind2):\n",
    "    \n",
    "    arg1_sign = \"**\"\n",
    "    arg2_sign = \"++\"\n",
    "    arg1_color, arg2_color = \"red\", \"blue\"\n",
    "    \n",
    "    if not ind2 > ind1: \n",
    "        ind1, ind2 = ind2, ind1\n",
    "        arg1_sign, arg2_sign = arg2_sign, arg1_sign\n",
    "        arg1_color, arg2_color = arg2_color, arg1_color\n",
    "        \n",
    "    splitted = sentence.split(\" \")\n",
    "    before_arg1 = \" \".join(splitted[:ind1])\n",
    "    arg1 = splitted[ind1]\n",
    "    arg2 = splitted[ind2]\n",
    "    between = \" \".join(splitted[ind1 + 1: ind2])\n",
    "    suffix = \" \".join(splitted[ind2+1:])\n",
    "    \n",
    "    return before_arg1 +  \" \" + arg1_sign + colored(arg1, arg1_color) + arg1_sign + \" \" + between + \" \" + arg2_sign + colored(arg2, arg2_color) + arg2_sign + \" \" + suffix\n",
    "\n",
    "\n",
    "\n",
    "def main(filename, layers = [-1]):\n",
    "    \n",
    "\n",
    "    query, results1 = load_results(filename)\n",
    "    spike_results = spike_queries.perform_query(query, dataset_name = \"covid19\", num_results = 50, query_type = \"syntactic\")\n",
    "    spike_results = spike_results[spike_results['sentence_text'].notnull()]\n",
    "    arg1_rep, arg2_rep = get_spike_results_arguments_representations(model, spike_results, layers)\n",
    "    \n",
    "    print(color.BOLD + \"QUERY\" + color.END + \":\\n{}\".format(query))\n",
    "    \n",
    "    first, first_ind1, first_ind2 = spike_results[\"sentence_text\"].tolist()[-1], int(spike_results[\"arg1_first_index\"].tolist()[-1]), int(spike_results[\"arg2_first_index\"].tolist()[-1])\n",
    "    print(color.BOLD + \"\\nFIRST SPIKE RESULT\" + color.END + \":\\n{}\".format(print_sentence_nicely(first, first_ind1, first_ind2)))\n",
    "    print(color.BOLD + \"\\nAUGMENTATION RESULTS:\\n\" + color.END)\n",
    "    \n",
    "    for s in results1:\n",
    "        H, tokenized_text, tok_to_orig_map, orig2tok = model.encode(s, layers = layers)\n",
    "        #print(\"H shape: {}\".format(H.shape))\n",
    "        sims_arg1 = cosine_similarity([arg1_rep], H[1:-2])[0]\n",
    "        sims_arg2 = cosine_similarity([arg2_rep], H[1:-2])[0]\n",
    "        arg1_ind = np.argmax(sims_arg1) + 1\n",
    "        \n",
    "        sims_arg2[np.argmax(sims_arg1)] = -1\n",
    "        arg2_ind = np.argmax(sims_arg2) + 1\n",
    "        #print(arg1_ind, arg2_ind)\n",
    "        if arg1_ind not in tok_to_orig_map or arg2_ind not in tok_to_orig_map:\n",
    "            print(\"ERROR\")\n",
    "            continue\n",
    "        print(print_sentence_nicely(s, tok_to_orig_map[arg1_ind], tok_to_orig_map[arg2_ind]))\n",
    "        print(\"-----------------------------------\")\n",
    "    \n",
    "    print(color.BOLD + \"=======================================================\" + color.END)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 457,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "loading configuration file https://s3.amazonaws.com/models.huggingface.co/bert/allenai/scibert_scivocab_uncased/config.json from cache at /home/shauli/.cache/torch/transformers/199e28e62d2210c23d63625bd9eecc20cf72a156b29e2a540d4933af4f50bda1.4b6b9f5d813f7395e7ea533039e02deb1723d8fd9d8ba655391a01a69ad6223d\n",
      "Model config BertConfig {\n",
      "  \"attention_probs_dropout_prob\": 0.1,\n",
      "  \"hidden_act\": \"gelu\",\n",
      "  \"hidden_dropout_prob\": 0.1,\n",
      "  \"hidden_size\": 768,\n",
      "  \"initializer_range\": 0.02,\n",
      "  \"intermediate_size\": 3072,\n",
      "  \"layer_norm_eps\": 1e-12,\n",
      "  \"max_position_embeddings\": 512,\n",
      "  \"model_type\": \"bert\",\n",
      "  \"num_attention_heads\": 12,\n",
      "  \"num_hidden_layers\": 12,\n",
      "  \"output_hidden_states\": true,\n",
      "  \"pad_token_id\": 0,\n",
      "  \"type_vocab_size\": 2,\n",
      "  \"vocab_size\": 31090\n",
      "}\n",
      "\n",
      "loading configuration file https://s3.amazonaws.com/models.huggingface.co/bert/allenai/scibert_scivocab_uncased/config.json from cache at /home/shauli/.cache/torch/transformers/199e28e62d2210c23d63625bd9eecc20cf72a156b29e2a540d4933af4f50bda1.4b6b9f5d813f7395e7ea533039e02deb1723d8fd9d8ba655391a01a69ad6223d\n",
      "Model config BertConfig {\n",
      "  \"attention_probs_dropout_prob\": 0.1,\n",
      "  \"hidden_act\": \"gelu\",\n",
      "  \"hidden_dropout_prob\": 0.1,\n",
      "  \"hidden_size\": 768,\n",
      "  \"initializer_range\": 0.02,\n",
      "  \"intermediate_size\": 3072,\n",
      "  \"layer_norm_eps\": 1e-12,\n",
      "  \"max_position_embeddings\": 512,\n",
      "  \"model_type\": \"bert\",\n",
      "  \"num_attention_heads\": 12,\n",
      "  \"num_hidden_layers\": 12,\n",
      "  \"pad_token_id\": 0,\n",
      "  \"type_vocab_size\": 2,\n",
      "  \"vocab_size\": 31090\n",
      "}\n",
      "\n",
      "Model name 'allenai/scibert_scivocab_uncased' not found in model shortcut name list (bert-base-uncased, bert-large-uncased, bert-base-cased, bert-large-cased, bert-base-multilingual-uncased, bert-base-multilingual-cased, bert-base-chinese, bert-base-german-cased, bert-large-uncased-whole-word-masking, bert-large-cased-whole-word-masking, bert-large-uncased-whole-word-masking-finetuned-squad, bert-large-cased-whole-word-masking-finetuned-squad, bert-base-cased-finetuned-mrpc, bert-base-german-dbmdz-cased, bert-base-german-dbmdz-uncased, bert-base-finnish-cased-v1, bert-base-finnish-uncased-v1, bert-base-dutch-cased). Assuming 'allenai/scibert_scivocab_uncased' is a path, a model identifier, or url to a directory containing tokenizer files.\n",
      "loading file https://s3.amazonaws.com/models.huggingface.co/bert/allenai/scibert_scivocab_uncased/vocab.txt from cache at /home/shauli/.cache/torch/transformers/e3debd8fbdf40874753724814ee0520f612b577b26c8755bca485103b47cd3bc.60287becc5ab96d85a4bf377eb90feaf3b9c80d3b23e84311dccd3588f56d4fb\n",
      "loading file https://s3.amazonaws.com/models.huggingface.co/bert/allenai/scibert_scivocab_uncased/added_tokens.json from cache at None\n",
      "loading file https://s3.amazonaws.com/models.huggingface.co/bert/allenai/scibert_scivocab_uncased/special_tokens_map.json from cache at None\n",
      "loading file https://s3.amazonaws.com/models.huggingface.co/bert/allenai/scibert_scivocab_uncased/tokenizer_config.json from cache at None\n",
      "loading weights file https://cdn.huggingface.co/allenai/scibert_scivocab_uncased/pytorch_model.bin from cache at /home/shauli/.cache/torch/transformers/54e18c298451d3195ba8359e7a3fa2bc04c70c730c5b6744928278e67940eacb.7587182ea55c40bf7fd0961c1176c31fa22558da2bf20c199874fa5a8ecb4613\n"
     ]
    }
   ],
   "source": [
    "model = bert.BertEncoder(\"cpu\", \"scibert\")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Alignment Experiments"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 514,
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\u001b[1mQUERY\u001b[0m:\n",
      "<>arg1:virus $infection $causes a <>arg2:condition .\n",
      "\u001b[1m\n",
      "FIRST SPIKE RESULT\u001b[0m:\n",
      "178 Thus , **\u001b[31mleishmania\u001b[0m** infection causes ++\u001b[34msecondary\u001b[0m++ infections , and activation/reactivation of dormant infections that can lead to severe or lethal outcomes through multiple mechanisms .\n",
      "\u001b[1m\n",
      "AUGMENTATION RESULTS:\n",
      "\u001b[0m\n",
      "In humans , **\u001b[31mJEV\u001b[0m** infection can cause Japanese encephalitis ( JE ) with ++\u001b[34msevere\u001b[0m++ central nervous system disorders .\n",
      "-----------------------------------\n",
      "Hepatotropic **\u001b[31mvirus\u001b[0m** , like MHV-3 infection in mice , can induce exaggerated ++\u001b[34minflammation\u001b[0m++ in the liver and cause life-threatening viral FH .\n",
      "-----------------------------------\n",
      "Human metapneumovirus ( hMPV ) **\u001b[31minfection\u001b[0m** causes respiratory tract ++\u001b[34mdisease\u001b[0m++ similar to that observed during human respiratory syncytial virus infection ( hRSV ) .\n",
      "-----------------------------------\n",
      "In humans , CHIKV **\u001b[31minfections\u001b[0m** cause a debilitating ++\u001b[34mdisease\u001b[0m++ with acute febrile illness and long-term polyarthralgia .\n",
      "-----------------------------------\n",
      " **\u001b[31mFIV\u001b[0m** infection causes ++\u001b[34mprogressive\u001b[0m++ immunosuppression that results in the development of the acquired immunodeficiency syndrome ( AIDS ) in cats , which , similar to human HIV infection , increases susceptibility to secondary and opportunistic infections .\n",
      "-----------------------------------\n",
      " **\u001b[31mHuman\u001b[0m** infection of H7N9 avian infl uenza virus directly induces ++\u001b[34mpneumonia\u001b[0m++ , with radiological signs of pneumonia early after onset .\n",
      "-----------------------------------\n",
      " **\u001b[31mMCMV\u001b[0m** causes asymptomatic infection in adult immunocompetent mice , but experimental inoculation of neonates has caused lethal ++\u001b[34mdisease\u001b[0m++ due to multisystemic necrosis and inflammation .\n",
      "-----------------------------------\n",
      " **\u001b[31mBRV\u001b[0m** is a lytic infection and destruction of infected mucosal epithelial cells is an important component of ++\u001b[34mdisease\u001b[0m++ pathogenesis .\n",
      "-----------------------------------\n",
      "As discussed above , coxsackievirus B3 ( CVB3 ) **\u001b[31minfection\u001b[0m**  ++\u001b[34mcauses\u001b[0m++ myocarditis in human beings as well as in male BALB/c mice .\n",
      "-----------------------------------\n",
      "In chickens , Infectious **\u001b[31mBronchitis\u001b[0m** ( IB ) causes severe ++\u001b[34minflammatory\u001b[0m++ lesions in the respiratory tract .\n",
      "-----------------------------------\n",
      " **\u001b[31mPEDV\u001b[0m** infects the epithelium of the small intestine , an environment rich in proteases , and causes atrophy of the villi resulting in ++\u001b[34mdiarrhea\u001b[0m++ and dehydration .\n",
      "-----------------------------------\n",
      "In humans , VEEV **\u001b[31minfection\u001b[0m** causes a sudden ++\u001b[34monset\u001b[0m++ of malaise , fever , chills , headache , and sore throat .\n",
      "-----------------------------------\n",
      "However , SARS-CoV **\u001b[31minfection\u001b[0m** results in severe and even fatal lung ++\u001b[34mdisease\u001b[0m++ in humans .\n",
      "-----------------------------------\n",
      " **\u001b[31mFIV\u001b[0m** is an important viral pathogen worldwide in the domestic cat ( Felis catus ) , causes a slow progressive degeneration of immune functions that eventually leads to a ++\u001b[34mdisease\u001b[0m++ .\n",
      "-----------------------------------\n",
      "In humans , coronavirus **\u001b[31minfection\u001b[0m** results in respiratory tract complications with varying degree of severity and has been associated with ++\u001b[34mgastroenteritis\u001b[0m++ .\n",
      "-----------------------------------\n",
      "In humans , the **\u001b[31mvirus\u001b[0m** causes a lower respiratory tract ++\u001b[34mdisease\u001b[0m++ and may progress to ARDS , multiorgan failure , and death in severe cases .\n",
      "-----------------------------------\n",
      "In pythons , **\u001b[31mnidovirus\u001b[0m** infection induces an inflammation of the upper respiratory and alimentary tract which can develop into a severe and often fatal proliferative ++\u001b[34mpneumonia\u001b[0m++ .\n",
      "-----------------------------------\n",
      " **\u001b[31mInfluenza\u001b[0m** virus infection in humans can lead to mild to severe ++\u001b[34millness\u001b[0m++ , as a result of both viral replication and the host immune response .\n",
      "-----------------------------------\n",
      "In hamsters , **\u001b[31mviral\u001b[0m**  ++\u001b[34mreplication\u001b[0m++ occurs in epithelial cells of the respiratory tract and causes interstitial pneumonia , pulmonary consolidation , and diffuse alveolar damage .\n",
      "-----------------------------------\n",
      "Although ++\u001b[34mdiarrhea\u001b[0m++ is recognized as the main clinical feature of **\u001b[31mBCV\u001b[0m** infections , BCV also causes respiratory tract infections in calves .\n",
      "-----------------------------------\n",
      " **\u001b[31mPRRSV\u001b[0m** increases the susceptibility of the host to a wide range of viral and bacterial respiratory pathogens , resulting in increased ++\u001b[34mseverity\u001b[0m++ of clinical signs and lung lesions .\n",
      "-----------------------------------\n",
      "\u001b[1m=======================================================\u001b[0m\n"
     ]
    }
   ],
   "source": [
    "main(\"results1.txt\", layers = [-1])"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Accuracy: 20/20"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 511,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\u001b[1mQUERY\u001b[0m:\n",
      "infected arg1:patients $usually $develop <>arg2:[entity]respiratory illness.\n",
      "\u001b[1m\n",
      "FIRST SPIKE RESULT\u001b[0m:\n",
      "12 , 27 , [ 33 ] [ 34 ] [ 35 ] **\u001b[31mPuppies\u001b[0m** that are nursing from CHV-seronegative dams usually develop the fatal ++\u001b[34mmultisystemic\u001b[0m++ disease , while puppies that suckle from CHV-seropositive dams remain asymptomatic but still become infected .\n",
      "\u001b[1m\n",
      "AUGMENTATION RESULTS:\n",
      "\u001b[0m\n",
      "After an incubation period of 5 to 14 days , SARS-CoV-2-infected **\u001b[31mpeople\u001b[0m** commonly manifest features of ++\u001b[34mpneumonia\u001b[0m++ , including fever , dry cough , dyspnoea , myalgia and fatigue .\n",
      "-----------------------------------\n",
      "After an incubation period of 2 to 3 days , **\u001b[31mpatients\u001b[0m** who have pneumonic plague typically develop fulminant ++\u001b[34mpneumonia\u001b[0m++ , with malaise , high fever , cough , hemoptysis , and septicemia with ecchymoses and extremity necrosis .\n",
      "-----------------------------------\n",
      " **\u001b[31mPatients\u001b[0m** suffering from severe DENV infection often exhibit encephalopathy and ++\u001b[34mencephalitis\u001b[0m++ .\n",
      "-----------------------------------\n",
      "Following an incubation period of usually 4 - 5 days , **\u001b[31mpatients\u001b[0m** infected with SARS-CoV often present with ++\u001b[34msymptoms\u001b[0m++ of fever , headache , and myalgias .\n",
      "-----------------------------------\n",
      " **\u001b[31mCats\u001b[0m** with FIP show nonspecific ++\u001b[34mclinical\u001b[0m++ signs such as fever , weight loss and anorexia , often accompanied by body cavity effusions and/or ocular and neurological signs .\n",
      "-----------------------------------\n",
      " **\u001b[31mCats\u001b[0m** with signs from FIV often ++\u001b[34mhave\u001b[0m++ lethargy , anorexia and weight loss associated with secondary infections of the skin , and gastrointestinal or respiratory tracts .\n",
      "-----------------------------------\n",
      " ++\u001b[34mEnteric\u001b[0m++ FCoV **\u001b[31minfection\u001b[0m** typically results in inappetence and/or mild gastrointestinal signs such as vomiting and diarrhea .\n",
      "-----------------------------------\n",
      "Most **\u001b[31mpatients\u001b[0m** with MERS develop severe acute ++\u001b[34mrespiratory\u001b[0m++ illness accompanied by fever , cough , and shortness of breath [ 50 ] .\n",
      "-----------------------------------\n",
      "The terminal stages of Ebola virus **\u001b[31minfection\u001b[0m** usually include diffuse ++\u001b[34mbleeding\u001b[0m++ , and hypotensive shock accounts for many Ebola virus fatalities .\n",
      "-----------------------------------\n",
      "In rats , **\u001b[31minfection\u001b[0m** is usually asymptomatic , although nonspecific ++\u001b[34mclinical\u001b[0m++ signs such as weight loss and dyspnea may occur .\n",
      "-----------------------------------\n",
      "Following an average incubation period of 20 days , infected **\u001b[31mpatients\u001b[0m** can present with ++\u001b[34msevere\u001b[0m++ headache , fever , chills , fatigue , and myalgia .\n",
      "-----------------------------------\n",
      " **\u001b[31mPatients\u001b[0m** infected with EVD rapidly deteriorate and commonly present with gastrointestinal ++\u001b[34msymptoms\u001b[0m++ including vomiting , diarrhea and dehydration .\n",
      "-----------------------------------\n",
      "Adult **\u001b[31mrabbits\u001b[0m** usually develop a chronic ++\u001b[34mdisease\u001b[0m++ course , which can lead to intestinal fi brosis , liver necrosis and stenosis , and myocardial disease .\n",
      "-----------------------------------\n",
      " **\u001b[31mCats\u001b[0m** are primarily infected subclinically , but gastrointestinal ++\u001b[34mdisease\u001b[0m++ manifested as enterocolitis and endotoxemia can occur and is initially associated with fever , malaise , and anorexia followed by vomiting , abdominal pain , and diarrhoea [ 7 ] .\n",
      "-----------------------------------\n",
      "Affected **\u001b[31mrabbits\u001b[0m** usually develop ++\u001b[34msepsis\u001b[0m++ , which quickly leads to death ; however , diarrhea may occur as well .\n",
      "-----------------------------------\n",
      "Affected **\u001b[31mrabbits\u001b[0m** usually develop ++\u001b[34msepsis\u001b[0m++ , which quickly leads to death ; however , diarrhea may occur as well .\n",
      "-----------------------------------\n",
      "Affected **\u001b[31mrabbits\u001b[0m** usually develop ++\u001b[34msepsis\u001b[0m++ , which quickly leads to death ; however , diarrhea may occur as well .\n",
      "-----------------------------------\n",
      "Common **\u001b[31mmarmosets\u001b[0m** with measles ++\u001b[34minfection\u001b[0m++ become clinically apparent with lethargy , facial edema , and nasal discharge and occasionally develop an exanthema .\n",
      "-----------------------------------\n",
      "In **\u001b[31mhumans\u001b[0m** , VEEV infection causes a ++\u001b[34msudden\u001b[0m++ onset of malaise , fever , chills , headache , and sore throat .\n",
      "-----------------------------------\n",
      " **\u001b[31mHumans\u001b[0m** infected with RVFV usually develop an acute febrile myalgic ++\u001b[34msyndrome\u001b[0m++ ; however , a small percentage of patients have a lethal illness that results in hepatic damage , hemorrhagic fever-like illness , encephalitis and/or retinal vasculitis [ 8 ] .\n",
      "-----------------------------------\n",
      "In humans , ++\u001b[34minfection\u001b[0m++ is associated with fever and liver damage , but a subset of **\u001b[31mpatients\u001b[0m** progress to hemorrhagic fever , encephalitis , ocular disease or death .\n",
      "-----------------------------------\n",
      "\u001b[1m=======================================================\u001b[0m\n"
     ]
    }
   ],
   "source": [
    "main(\"results2.txt\", [-1])"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Accuracy: 19/20"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 510,
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\u001b[1mQUERY\u001b[0m:\n",
      "a arg1:subset of patients  $progress to arg2:hemorrhagic fever\n",
      "\u001b[1m\n",
      "FIRST SPIKE RESULT\u001b[0m:\n",
      "The **\u001b[31mdisease\u001b[0m** may progress across the bone of the skull base to the ++\u001b[34mjugular\u001b[0m++ foramen and hypoglossal canal , resulting in palsies of the ninth , tenth , eleventh and twelfth cranial nerves .\n",
      "\u001b[1m\n",
      "AUGMENTATION RESULTS:\n",
      "\u001b[0m\n",
      " ++\u001b[34mSevere\u001b[0m++  **\u001b[31mcases\u001b[0m** may progress to a capillary leak syndrome with septic shock , rash , facial and neck swelling , and multi-organ system failure .\n",
      "-----------------------------------\n",
      "When symptoms occur , IPS **\u001b[31mmay\u001b[0m** rapidly progress to ++\u001b[34mpulmonary\u001b[0m++ dysfunction requiring mechanical ventilation .\n",
      "-----------------------------------\n",
      " ++\u001b[34mClinical\u001b[0m++ signs are nonspecific in the early stages , but as the **\u001b[31mdisease\u001b[0m** progresses to involve more of the liver and impair regeneration , icterus , ascites , and hepatic encephalopathy may develop as typical correlates with hepatic insufficiency .\n",
      "-----------------------------------\n",
      "The **\u001b[31mpatients\u001b[0m** can develop radiographic findings of bilateral pulmonary opacities [ 9 ] , and they can progress to respiratory failure in ++\u001b[34msevere\u001b[0m++ cases .\n",
      "-----------------------------------\n",
      "Untreated **\u001b[31mcases\u001b[0m** of DPB typically progress to bronchiectasis and ++\u001b[34mrespiratory\u001b[0m++ failure .\n",
      "-----------------------------------\n",
      " **\u001b[31mSymptoms\u001b[0m** can progress to a ++\u001b[34msevere\u001b[0m++ form of pneumonia with critical complications , including septic shock , pulmonary edema , acute respiratory distress syndrome and multi-organ failure .\n",
      "-----------------------------------\n",
      "Rarely , **\u001b[31msymptoms\u001b[0m** may progress to ++\u001b[34mrespiratory\u001b[0m++ failure , shock or multiorgan dysfunction .\n",
      "-----------------------------------\n",
      " **\u001b[31mThis\u001b[0m** infection usually begins as a ++\u001b[34mviral\u001b[0m++ croup but progresses rapidly with high fever , toxicity , and worsening respiratory distress .\n",
      "-----------------------------------\n",
      " ++\u001b[34mMild\u001b[0m++  **\u001b[31mdisease\u001b[0m** may resolve without medical care or may progress to pneumonia and respiratory failure requiring hospitalization .\n",
      "-----------------------------------\n",
      "In ++\u001b[34msevere\u001b[0m++ cases , dyspnea and/or hypoxemia usually occur one week after the onset of the **\u001b[31mdisease\u001b[0m** , and in severe cases , it rapidly progresses to acute respiratory distress syndrome , septic shock , metabolic acidosis that is difficult to correct , and bleeding and coagulation dysfunction .\n",
      "-----------------------------------\n",
      "The **\u001b[31mdisease\u001b[0m** may progress to encephalitis ++\u001b[34mwith\u001b[0m++ drowsiness , disorientation , convulsions , and coma .\n",
      "-----------------------------------\n",
      " **\u001b[31mThis\u001b[0m** worsening can present as ++\u001b[34mrecurrent\u001b[0m++ fever 4 to 7 days after initial defervescence , new chest infiltrates , respiratory failure , or watery diarrhea .\n",
      "-----------------------------------\n",
      "While **\u001b[31mdisease\u001b[0m** is often mild with cold-like symptoms , it can progress to ++\u001b[34msevere\u001b[0m++ presentations such as bronchiolitis or pneumonia requiring hospitalization or resulting in death .\n",
      "-----------------------------------\n",
      " **\u001b[31mPatients\u001b[0m** may progress to ++\u001b[34macute\u001b[0m++ respiratory distress syndrome , neurological impairment with encephalopathy , and seizures .\n",
      "-----------------------------------\n",
      "Usually , the **\u001b[31mdisease\u001b[0m** progresses very slowly , but can result in ++\u001b[34mcardiac\u001b[0m++ and pulmonary failure .\n",
      "-----------------------------------\n",
      "Usually , the **\u001b[31mdisease\u001b[0m** progresses very slowly , but can result in ++\u001b[34mcardiac\u001b[0m++ and pulmonary failure .\n",
      "-----------------------------------\n",
      "In ++\u001b[34msevere\u001b[0m++  **\u001b[31mcases\u001b[0m** , the illness can progress to the development of interstitial pneumonia , acute respiratory distress syndrome , meningoencephalitis , acute kidney injury , or disseminated intravascular coagulation .\n",
      "-----------------------------------\n",
      "The **\u001b[31mdisease\u001b[0m** can rapidly progress to the hemorrhagic phase of ++\u001b[34mdisease\u001b[0m++ , during which patients exhibit petechiae , hematomas/ecchymosis , and hemorrhages from various sites around the body .\n",
      "-----------------------------------\n",
      "In some **\u001b[31mpatients\u001b[0m** , the signs may progress to a ++\u001b[34msecondary\u001b[0m++ bronchopneumonia .\n",
      "-----------------------------------\n",
      " **\u001b[31mThey\u001b[0m** may begin with an afebrile watery diarrhea syndrome and then progress to fever ++\u001b[34mand\u001b[0m++ bacteremia .\n",
      "-----------------------------------\n",
      "In ++\u001b[34msevere\u001b[0m++ cases , the **\u001b[31mdisease\u001b[0m** may progress to respiratory , circulatory , and renal failure , and ultimately death due to multiorgan failure .\n",
      "-----------------------------------\n",
      "\u001b[1m=======================================================\u001b[0m\n"
     ]
    }
   ],
   "source": [
    "main(\"results3.txt\", [-1])"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Accuarcy: 13/20"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 509,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\u001b[1mQUERY\u001b[0m:\n",
      "people with arg1:[e]asthma are $susceptible to arg2:[e]asthma\n",
      "\u001b[1m\n",
      "FIRST SPIKE RESULT\u001b[0m:\n",
      "However , children with inborn **\u001b[31merrors\u001b[0m** in TLR3 signaling ( 54 ) ( 55 ) ( 56 ) or defects resulting in abnormal signaling through several antiviral TLRs including 3 , 7 , 8 , 9 ( e.g. UNC-93B deficiency)(57 ) are susceptible to ++\u001b[34mHSVE\u001b[0m++ .\n",
      "\u001b[1m\n",
      "AUGMENTATION RESULTS:\n",
      "\u001b[0m\n",
      "Patients with lung **\u001b[31mcancer\u001b[0m** are highly susceptible to ++\u001b[34minfection\u001b[0m++ compared to healthy individuals because of systemic immunosuppression induced by malignancy and anticancer therapy .\n",
      "-----------------------------------\n",
      "Patients with lung **\u001b[31mcancer\u001b[0m** are highly susceptible to ++\u001b[34minfection\u001b[0m++ compared to healthy individuals because of systemic immunosuppression induced by malignancy and anticancer therapy .\n",
      "-----------------------------------\n",
      " **\u001b[31mPatients\u001b[0m** with ARDS triggered by viral ++\u001b[34minfection\u001b[0m++ , in particular influenza , are prone to invasive aspergillosis even in absence of prior immunodeficiency .\n",
      "-----------------------------------\n",
      " **\u001b[31mPatients\u001b[0m** with immunodeficiency due to human immunodeficiency virus ( HIV ) infection are highly susceptible to viral ++\u001b[34msepsis\u001b[0m++ depending on the stage of disease and access and response to the treatment ( 19 ) .\n",
      "-----------------------------------\n",
      "Individuals with **\u001b[31mdiabetes\u001b[0m** , immunosuppressive disorders , and liver disease including hemochromatosis and alcoholic liver disease are especially susceptible to ++\u001b[34minfection\u001b[0m++ .\n",
      "-----------------------------------\n",
      "Patients with **\u001b[31mcancer\u001b[0m** are more susceptible to the ++\u001b[34minfection\u001b[0m++ owing to their immunocompromised state .\n",
      "-----------------------------------\n",
      "Individuals with **\u001b[31mSCD\u001b[0m** are strongly susceptible to encapsulated bacterial ++\u001b[34morganisms\u001b[0m++ such as S. pneumoniae , a common colonizer of the nasopharynx in healthy children .\n",
      "-----------------------------------\n",
      "However , immunocompromised individuals , both children and adults , are prone to develop severe **\u001b[31millness\u001b[0m** as a result of HPIV ++\u001b[34minfection\u001b[0m++ .\n",
      "-----------------------------------\n",
      "Affected **\u001b[31mindividuals\u001b[0m** are immunosuppressed , and therefore , are more susceptible to ++\u001b[34minfluenza\u001b[0m++ , viral enteritis , and distemper [ 1 , 26 ] .\n",
      "-----------------------------------\n",
      "Due to the physiological changes in their immune and cardiopulmonary systems , pregnant women are more likely to develop severe **\u001b[31millness\u001b[0m** after ++\u001b[34minfection\u001b[0m++ with respiratory viruses .\n",
      "-----------------------------------\n",
      "Due to the physiological changes in their immune and cardiopulmonary systems , pregnant women are more likely to develop severe **\u001b[31millness\u001b[0m** after ++\u001b[34minfection\u001b[0m++ with respiratory viruses .\n",
      "-----------------------------------\n",
      "Patients with **\u001b[31mcancer\u001b[0m** are known to be at an increased risk for community-acquired respiratory ++\u001b[34mviruses\u001b[0m++ , such as influenza , because of their frequently observed immunocompromised state .\n",
      "-----------------------------------\n",
      "Moreover , dialysis **\u001b[31mpatients\u001b[0m** are more vulnerable to ++\u001b[34minfection\u001b[0m++ due to suppression of the immune system .\n",
      "-----------------------------------\n",
      "Moreover , **\u001b[31mchildren\u001b[0m** receiving immunomodulatory or immunosuppressive therapies due to malignancy , transplantation , or autoimmune disease are more susceptible to viral ++\u001b[34minfection\u001b[0m++ or reactivation .\n",
      "-----------------------------------\n",
      "Patients with **\u001b[31mDS\u001b[0m** are highly susceptible to lower and higher respiratory tract ++\u001b[34minfection\u001b[0m++ .\n",
      "-----------------------------------\n",
      "Patients with **\u001b[31mDS\u001b[0m** are highly susceptible to lower and higher respiratory tract ++\u001b[34minfection\u001b[0m++ .\n",
      "-----------------------------------\n",
      "Patients with **\u001b[31mDS\u001b[0m** are highly susceptible to lower and higher respiratory tract ++\u001b[34minfection\u001b[0m++ .\n",
      "-----------------------------------\n",
      "Elderly **\u001b[31mpatients\u001b[0m** are also more prone to RSV ++\u001b[34minfections\u001b[0m++ due to their decreased immunologic response to the virus [ 13 ] .\n",
      "-----------------------------------\n",
      "Although the incidence of RSV ++\u001b[34minfection\u001b[0m++ is low among patients with **\u001b[31mAML\u001b[0m** , it is associated with high mortality in children with AML [ 21 ] , and it is well known that infants , both immunocompetent and immunocompromised , are particularly vulnerable to RSV .\n",
      "-----------------------------------\n",
      "Patients with severe virus **\u001b[31minfection\u001b[0m** are more likely to be co-infected with ++\u001b[34mbacteria\u001b[0m++ due to low immune functions [ 24 ] .\n",
      "-----------------------------------\n",
      " **\u001b[31mCancer\u001b[0m** patients are at an increased risk for these ++\u001b[34minfections\u001b[0m++ due to their immunosuppressed states .\n",
      "-----------------------------------\n",
      "\u001b[1m=======================================================\u001b[0m\n"
     ]
    }
   ],
   "source": [
    "main(\"results4.txt\", [-1])"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Accuracy: 16/20"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 508,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\u001b[1mQUERY\u001b[0m:\n",
      "arg1:[e]paracetamol is $not useful for treating arg2:[e]asthma.\n",
      "\u001b[1m\n",
      "FIRST SPIKE RESULT\u001b[0m:\n",
      "There are cases of ADEM or even fulminant presentation such as AHL where **\u001b[31msteroids\u001b[0m** alone are not sufficient for suppressing ++\u001b[34minflammation\u001b[0m++ and improving clinical findings .\n",
      "\u001b[1m\n",
      "AUGMENTATION RESULTS:\n",
      "\u001b[0m\n",
      "However , while tocilizumab is a promising agent against COVID-19 , **\u001b[31mit\u001b[0m** is not an appropriate agent in patients with active or latent ++\u001b[34mtuberculosis\u001b[0m++ , bacterial and fungal infections , multi-organ failure , and gastrointestinal perforation [ 7 ] .\n",
      "-----------------------------------\n",
      "There are cases of ADEM or even fulminant presentation such as AHL where **\u001b[31msteroids\u001b[0m** alone are not sufficient for suppressing ++\u001b[34minflammation\u001b[0m++ and improving clinical findings .\n",
      "-----------------------------------\n",
      "Thus , **\u001b[31mribavirin\u001b[0m** may not be useful for treating ++\u001b[34mSARS\u001b[0m++ infections because of its questionable efficacy and because of its known toxicity ( reviewed by van Vonderen et al. , 2003 ; Lai , 2005 ) .\n",
      "-----------------------------------\n",
      "In general , steroid **\u001b[31mtherapy\u001b[0m** is not recommended in the clinical treatment ++\u001b[34mof\u001b[0m++ SARS-CoV-2 [ 103 ] .\n",
      "-----------------------------------\n",
      "In fact , **\u001b[31msteroids\u001b[0m** are not recommended in COVID-19 ++\u001b[34minfection\u001b[0m++ outside of clinical trial because of potential increased risk of mechanical ventilation ( 10 ) .\n",
      "-----------------------------------\n",
      " ++\u001b[34mPatients\u001b[0m++ with PCP typically die due to refractory hypoxemia from severe respiratory failure , and **\u001b[31mcorticosteroids\u001b[0m** have failed to demonstrate benefit outside of the HIV population [ 62 , 63 ] .\n",
      "-----------------------------------\n",
      "In addition , **\u001b[31msteroids\u001b[0m** are not effective for the treatment of lung injury or shock in adults ' SARS-CoV-2 ++\u001b[34minfection\u001b[0m++ [ 11 ] .\n",
      "-----------------------------------\n",
      " **\u001b[31mCorticosteroids\u001b[0m** in the treatment of SARS-CoV-2 pneumonia are not usually recommended ; they may delay ++\u001b[34mvirus\u001b[0m++ clearance from the body [ 1 , 3 ] .\n",
      "-----------------------------------\n",
      "At present , there is no effective therapeutic agent against CVB3 , and only **\u001b[31mribavirin\u001b[0m** is available for CVB3 ++\u001b[34minfection\u001b[0m++ despite its weak antiviral activity [ 93 ] .\n",
      "-----------------------------------\n",
      " **\u001b[31mDrugs\u001b[0m** currently licensed for the treatment of systemic ++\u001b[34mCMV\u001b[0m++ infections have limited therapeutic effectiveness due to dose-limiting toxicities , and prolonged therapy often results in resistance ( Biron , 2006 ) .\n",
      "-----------------------------------\n",
      "Most of the TCM **\u001b[31magents\u001b[0m** are mildly effective and slow-acting , and therefore , should not be used as the only treatment modality due to the rapid progression of ++\u001b[34mdisease\u001b[0m++ .\n",
      "-----------------------------------\n",
      "In addition , **\u001b[31mantivirals\u001b[0m** such as NA inhibitors and M2 blockers have limited efficacy in severe cases of ++\u001b[34minfluenza\u001b[0m++ infection if not administered within 48 hours from symptoms onset and may select for resistance .\n",
      "-----------------------------------\n",
      "The efficacy rate is also low in ++\u001b[34mchildren\u001b[0m++ , and the **\u001b[31mtreatment\u001b[0m** is normally ineffective in secondary ITP with underlying diseases , such as systemic lupus erythematosus [ 25 ] .\n",
      "-----------------------------------\n",
      "However , the use of **\u001b[31mcorticosteroids\u001b[0m** in the treatment of COVID-19 can cause ++\u001b[34mhost\u001b[0m++ immune suppression and delay viral clearance .\n",
      "-----------------------------------\n",
      "However , the clinical use of **\u001b[31minterferon\u001b[0m** to treat ++\u001b[34mdengue\u001b[0m++ is not common , possibly due to IFN-Î± side effects associated with its systemic activity .\n",
      "-----------------------------------\n",
      "Unfortunately , a consistent benefit has not been observed in all clinical trials and **\u001b[31mribavirin\u001b[0m** is currently not considered to be a drug of choice for ++\u001b[34minfluenza\u001b[0m++ .\n",
      "-----------------------------------\n",
      "For HSV ++\u001b[34mencephalitis\u001b[0m++ , the efficacy of **\u001b[31maciclovir\u001b[0m** monotherapy may be hampered by limited penetration of the drug in the central nervous system .\n",
      "-----------------------------------\n",
      "Although , in a substantial cooperative study , high-dose **\u001b[31macyclovir\u001b[0m** has had certain efficacy for preventing CMV ++\u001b[34mdisease\u001b[0m++ ( 101 ) , its utility is limited in a setting where more potent anti-CMV agents ( e.g. , ganciclovir ) are used ( 102 ) .\n",
      "-----------------------------------\n",
      "While **\u001b[31mFAM\u001b[0m** is standard therapy for established BOS , recent data argue strongly against using azithromycin as prophylaxis against BOS due to decreased ++\u001b[34msurvival\u001b[0m++ due to a higher rate of hematologic relapse [ 83 ] .\n",
      "-----------------------------------\n",
      "Although a number of antivirals are available for ++\u001b[34minfluenza\u001b[0m++ infections ( e.g. , M2 and neuraminidase inhibitors ) , these **\u001b[31mdrugs\u001b[0m** have only modest efficacy and their use is further limited by resistance that is either preexisting or is rapidly induced during treatment ( 192 ) .\n",
      "-----------------------------------\n",
      "Although immunosuppression is a mainstay of treatment for autoimmunity , IPEX **\u001b[31mtreatment\u001b[0m** is frequently limited by insufficient response to therapy or side effects of ++\u001b[34mimmune\u001b[0m++ suppression .\n",
      "-----------------------------------\n",
      "\u001b[1m=======================================================\u001b[0m\n"
     ]
    }
   ],
   "source": [
    "main(\"results5.txt\", [-1])"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Accuracy: 15/20"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 507,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\u001b[1mQUERY\u001b[0m:\n",
      "arg1:[e]stroke is a $complication of :[e]COVID-19 arg2:infection\n",
      "\u001b[1m\n",
      "FIRST SPIKE RESULT\u001b[0m:\n",
      "In conclusion , hepatic **\u001b[31minjury\u001b[0m** is likely a complication of COVID-19 ++\u001b[34minfection\u001b[0m++ .\n",
      "\u001b[1m\n",
      "AUGMENTATION RESULTS:\n",
      "\u001b[0m\n",
      "Acute kidney **\u001b[31minjury\u001b[0m** is a possible manifestation in ++\u001b[34msevere\u001b[0m++ forms of COVID-19 , conferring a high mortality 7 .\n",
      "-----------------------------------\n",
      "Coagulation dysfunction is one of the major causes for **\u001b[31mdeath\u001b[0m** in ++\u001b[34mpatients\u001b[0m++ with severe COVID-19 [ 4 ] .\n",
      "-----------------------------------\n",
      "ERROR\n",
      " **\u001b[31mHypoxia\u001b[0m** is the most common manifestation of ++\u001b[34mpatients\u001b[0m++ with COVID-19 , especially in severely or critically ill patients .\n",
      "-----------------------------------\n",
      "Early-onset **\u001b[31mpneumonia\u001b[0m** is a common and severe complication that is related to aspiration in ++\u001b[34mpatients\u001b[0m++ with GBS .\n",
      "-----------------------------------\n",
      " **\u001b[31mBarotrauma\u001b[0m** is a common complication in ++\u001b[34mpatients\u001b[0m++ with SARS .\n",
      "-----------------------------------\n",
      "COVID-19 **\u001b[31minfection\u001b[0m**  ++\u001b[34mis\u001b[0m++ associated with several cardiac complications with high rates of adverse outcomes .\n",
      "-----------------------------------\n",
      "COVID-19 **\u001b[31minfection\u001b[0m**  ++\u001b[34mis\u001b[0m++ associated with several cardiac complications with high rates of adverse outcomes .\n",
      "-----------------------------------\n",
      " **\u001b[31mAKI\u001b[0m**  ++\u001b[34mis\u001b[0m++ one of the common complications with COVID-19 , and is associated with increased morbidity and mortality .\n",
      "-----------------------------------\n",
      "Spontaneous **\u001b[31mpneumothorax\u001b[0m** is a specific and potentially life-threatening complication in SARS ++\u001b[34mpatients\u001b[0m++ .\n",
      "-----------------------------------\n",
      "COVID-19 **\u001b[31mpneumonia\u001b[0m**  ++\u001b[34mmay\u001b[0m++ lead to acute respiratory distress syndrome and severe respiratory failure ( 1 ) .\n",
      "-----------------------------------\n",
      " **\u001b[31mPneumonia\u001b[0m** is the most frequent and serious complication ++\u001b[34mof\u001b[0m++ COVID-19 , due to excessive host immune response causing an acute respiratory distress syndrome .\n",
      "-----------------------------------\n",
      "Acute respiratory distress syndrome developing in patients with COVID-19 **\u001b[31mpneumonia\u001b[0m** is associated with a high mortality rate and is the main cause of death in patients with SRAS-Cov-2 ++\u001b[34minfection\u001b[0m++ [ 1 ] .\n",
      "-----------------------------------\n",
      " **\u001b[31mPneumonia\u001b[0m** is a life-threatening complication of COVID-19 ++\u001b[34minfection\u001b[0m++ 10 .\n",
      "-----------------------------------\n",
      "ARDS and **\u001b[31mshock\u001b[0m** are common complications that can lead to death in COVID-19 ++\u001b[34mpatients\u001b[0m++ .\n",
      "-----------------------------------\n",
      "Multiorgan **\u001b[31minjury\u001b[0m** , which significantly increases mortality , is often evident in ++\u001b[34mpatients\u001b[0m++ with COVID-19 .\n",
      "-----------------------------------\n",
      "Acute **\u001b[31mIH\u001b[0m** is a significant complication of high-dose IVIg ++\u001b[34minfusion\u001b[0m++ .\n",
      "-----------------------------------\n",
      "Multiorgan failure and disseminated intravascular coagulation ( **\u001b[31mDIC\u001b[0m** ) are also frequently observed during COVID-19 ++\u001b[34minfection\u001b[0m++ .\n",
      "-----------------------------------\n",
      "Acute Respiratory Distress Syndrome ( **\u001b[31mARDS\u001b[0m** ) is one of the commonest complications developing in ++\u001b[34mpatients\u001b[0m++ with COVID-19 [ 6 ] .\n",
      "-----------------------------------\n",
      "Cardiac **\u001b[31minjury\u001b[0m** is a common condition among the hospitalized ++\u001b[34mpatients\u001b[0m++ with COVID-19 .\n",
      "-----------------------------------\n",
      " **\u001b[31mDIC\u001b[0m** is a severe complication in COVID-19 ++\u001b[34mpatients\u001b[0m++ and it has been related to poor prognosis and increased mortality ( 71.4 % of patient who die of COVID-19 ) ( 2 ) .\n",
      "-----------------------------------\n",
      "\u001b[1m=======================================================\u001b[0m\n"
     ]
    }
   ],
   "source": [
    "main(\"results6.txt\", [-1])"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Accuracy: 16/20"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 505,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\u001b[1mQUERY\u001b[0m:\n",
      "the recommended arg1:[w]quarantine period is arg2:14 :[w]days\n",
      "\u001b[1m\n",
      "FIRST SPIKE RESULT\u001b[0m:\n",
      "The CERs of interventions was unstable when the **\u001b[31mquarantine\u001b[0m** delay-time was no less than ++\u001b[34mfive\u001b[0m++ days ( figure 2d ) .\n",
      "\u001b[1m\n",
      "AUGMENTATION RESULTS:\n",
      "\u001b[0m\n",
      "If we aim to control the failure rate of quarantine to be below 1 % with 95 % confidence , then the **\u001b[31mquarantine\u001b[0m** period must be at least ++\u001b[34m22\u001b[0m++ days .\n",
      "-----------------------------------\n",
      "In general , the duration of the **\u001b[31mquarantine\u001b[0m** period should be 21 to ++\u001b[34m30\u001b[0m++ days .\n",
      "-----------------------------------\n",
      "Although for extreme cases , the **\u001b[31mquarantine\u001b[0m** period should be extended up to ++\u001b[34mthree\u001b[0m++ weeks .\n",
      "-----------------------------------\n",
      "At the beginning and the end of a SARS epidemic , to control the epidemic completely , we recommend a period of ++\u001b[34m22\u001b[0m++ days for **\u001b[31mquarantine\u001b[0m** , which would capture 99 percent of all probable SARS cases with a probability of 0.9 .\n",
      "-----------------------------------\n",
      "Based on the 95th percentile estimate of the incubation period , we recommend that the length of **\u001b[31mquarantine\u001b[0m** should be at least ++\u001b[34m14\u001b[0m++ days .\n",
      "-----------------------------------\n",
      "Based on the 95th percentile estimate of the incubation period , we recommend that the length of **\u001b[31mquarantine\u001b[0m** should be at least ++\u001b[34m14\u001b[0m++ days .\n",
      "-----------------------------------\n",
      "As such , the **\u001b[31mquarantine\u001b[0m** period should be extended up to ++\u001b[34mthree\u001b[0m++ weeks .\n",
      "-----------------------------------\n",
      "For example , if the rate of transmission is reduced by 10 % , the **\u001b[31mquarantine\u001b[0m** from symptom onset needs to be implemented ++\u001b[34mwithin\u001b[0m++ 32.37 h.\n",
      "-----------------------------------\n",
      "If testing is not done , the **\u001b[31mquarantine\u001b[0m**  ++\u001b[34mperiod\u001b[0m++ should at least exceed the incubation and shedding period of the diseases of concern .\n",
      "-----------------------------------\n",
      "Therefore , the **\u001b[31mquarantine\u001b[0m** period should be around ++\u001b[34m2\u001b[0m++ weeks after a close contact with a person with symptoms .\n",
      "-----------------------------------\n",
      "As per the CDC guidelines , ++\u001b[34m14\u001b[0m++ days should be the period of **\u001b[31mquarantine\u001b[0m** ( Science Daily website ) .\n",
      "-----------------------------------\n",
      "The **\u001b[31mquarantine\u001b[0m** period is typically ++\u001b[34m30\u001b[0m++ days .\n",
      "-----------------------------------\n",
      "Because a longer and more volatile incubation period has been observed in travelers , the duration of **\u001b[31mquarantine\u001b[0m** should be extended to ++\u001b[34m3\u001b[0m++ weeks .\n",
      "-----------------------------------\n",
      "The time for which a patient can infect others varies between 7 and ++\u001b[34m14\u001b[0m++ days for moderate cases according to [ 3 ] , and this is why **\u001b[31mquarantine\u001b[0m** should last at least two weeks .\n",
      "-----------------------------------\n",
      "Therefore , we suggest that the appropriate duration of **\u001b[31mquarantine\u001b[0m** is ++\u001b[34m4\u001b[0m++ days .\n",
      "-----------------------------------\n",
      "A **\u001b[31mquarantine\u001b[0m** period of at least ++\u001b[34m15\u001b[0m++ days should allow adequate time for the return and evaluation of test data .\n",
      "-----------------------------------\n",
      "At the moment , the WHO-established **\u001b[31mquarantine\u001b[0m** period is ++\u001b[34m14\u001b[0m++ days based on previous reports which had studied small sizes of hospitalized cases ( 10 and ~100 , respectively ) , however , over 80 % of adult- and 95 % of child-cases were not necessary to stay in hospitals , and therefore , had not been hospitalized .\n",
      "-----------------------------------\n",
      "The temporary storage **\u001b[31mtime\u001b[0m** for COVID-19 related medical waste in the hospital should not exceed ++\u001b[34m24\u001b[0m++ hours .\n",
      "-----------------------------------\n",
      " **\u001b[31mQuarantine\u001b[0m** duration depends on national regulations but should be a minimum of ++\u001b[34m30\u001b[0m++ days .\n",
      "-----------------------------------\n",
      "We recommend that the duration of **\u001b[31mquarantine\u001b[0m** should be at least ++\u001b[34m14\u001b[0m++ days on the basis of the 95th percentile estimate of the incubation period ( 10 ) .\n",
      "-----------------------------------\n",
      "A minimum **\u001b[31mquarantine\u001b[0m** period of 60 to ++\u001b[34m90\u001b[0m++ days is recommended in a building that is separate from the main facility .\n",
      "-----------------------------------\n",
      "\u001b[1m=======================================================\u001b[0m\n"
     ]
    }
   ],
   "source": [
    "main(\"results7.txt\", [-1])"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Accuracy: 19/20"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 504,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\u001b[1mQUERY\u001b[0m:\n",
      "arg1:[e]COVID-19 $infects arg2:cells\n",
      "\u001b[1m\n",
      "FIRST SPIKE RESULT\u001b[0m:\n",
      "Besides the lung , the **\u001b[31mSARS-CoV-2\u001b[0m** virus also infects the ++\u001b[34mGI\u001b[0m++ tract , causing the patients also to experience diarrhea .\n",
      "\u001b[1m\n",
      "AUGMENTATION RESULTS:\n",
      "\u001b[0m\n",
      " **\u001b[31mSARS-CoV-2\u001b[0m** infects ACE2positive ++\u001b[34mcells\u001b[0m++ in the oral mucosa and lungs , including ACE2 + AT2 cells in the alveoli .\n",
      "-----------------------------------\n",
      "SARS-CoV targets human angiotensin-converting enzyme **\u001b[31m2\u001b[0m** ( hACE2 ) and infects intrapulmonary epithelial ++\u001b[34mcells\u001b[0m++ more than cells of the upper airways [ 13 , 14 ] .\n",
      "-----------------------------------\n",
      "Initially , **\u001b[31mSARS-CoV-2\u001b[0m** infects ++\u001b[34mcells\u001b[0m++ in the respiratory system and causes inflammation and cell death .\n",
      "-----------------------------------\n",
      " **\u001b[31mSARS-CoV-2\u001b[0m** infects ACE2 + ++\u001b[34mcells\u001b[0m++ in the oral mucosa and lungs , including ACE-2 cells in the alveoli [ 97 ] .\n",
      "-----------------------------------\n",
      "In the lungs , **\u001b[31mSARS-CoV-2\u001b[0m** infects type I and type II alveolar epithelial ++\u001b[34mcells\u001b[0m++ , as well as alveolar macrophages that are among the first producers of pro-inflammatory cytokines .\n",
      "-----------------------------------\n",
      " **\u001b[31mSARS-CoV-2\u001b[0m** predominantly invades alveolar epithelial cells by binding to the ACE-2 receptor and then replicates within ++\u001b[34mcells\u001b[0m++ .\n",
      "-----------------------------------\n",
      "The **\u001b[31mSARS-Cov-2\u001b[0m** first predominantly infects lower airways and binds to ACE2 on ++\u001b[34malveolar\u001b[0m++ epithelial cells .\n",
      "-----------------------------------\n",
      "Studies have shown that **\u001b[31mSARS-CoV-2\u001b[0m** infects the GI ++\u001b[34mtract\u001b[0m++ via its viral receptor angiotensin converting enzyme II , which is expressed on enterocytes of the ileum and colon .\n",
      "-----------------------------------\n",
      "Studies have shown that **\u001b[31mSARS-CoV-2\u001b[0m** infects the GI ++\u001b[34mtract\u001b[0m++ via its viral receptor angiotensin converting enzyme II , which is expressed on enterocytes of the ileum and colon .\n",
      "-----------------------------------\n",
      " **\u001b[31mSARS-CoV-2\u001b[0m** infects human epithelial ++\u001b[34mcells\u001b[0m++ through the host cell receptor angiotensin-converting enzyme II ( ACE2 ) , which is expressed on cells lining the lungs , oral buccal and gingiva ( 19 ) .\n",
      "-----------------------------------\n",
      " **\u001b[31mSARS-CoV-2\u001b[0m** binds to the ACE2 receptor on ciliated bronchial epithelial ++\u001b[34mcells\u001b[0m++ to gain entry into these cells for viral replication and dissemination in the airway and systemically .\n",
      "-----------------------------------\n",
      "In terms of pathogenesis , **\u001b[31mSARS-CoV-2\u001b[0m** recognizes the angiotensin converting enzyme 2 receptor ( ACE2 ) by ++\u001b[34mits\u001b[0m++ spike protein .\n",
      "-----------------------------------\n",
      "Like other coronaviruses , **\u001b[31mSARS-CoV-2\u001b[0m** recognizes the human Angiotensin Converting Enzyme 2 ( hACE2 ) as a cellular receptor that allows it to infect different host ++\u001b[34mcells\u001b[0m++ , and likely disrupts the renin-angiotensin-aldosterone system ( RAAS ) homeostasis .\n",
      "-----------------------------------\n",
      "Like other coronaviruses , **\u001b[31mSARS-CoV-2\u001b[0m** recognizes the human Angiotensin Converting Enzyme 2 ( hACE2 ) as a cellular receptor that allows it to infect different host ++\u001b[34mcells\u001b[0m++ , and likely disrupts the renin-angiotensin-aldosterone system ( RAAS ) homeostasis .\n",
      "-----------------------------------\n",
      "Both SARS-CoV and HCoV-NL63 use angiotensin-converting enzyme **\u001b[31m2\u001b[0m** as the cellular receptor to infect host ++\u001b[34mcells\u001b[0m++ .\n",
      "-----------------------------------\n",
      "Like other viruses , **\u001b[31mSARS-CoV-2\u001b[0m** infects lung alveolar epithelial ++\u001b[34mcells\u001b[0m++ using receptor-mediated endocytosis via the angiotensin-converting enzyme II ( ACE2 ) as an entry receptor [ 4 ] .\n",
      "-----------------------------------\n",
      "Although the pathology of **\u001b[31mCOVID-19\u001b[0m** lung injury has not yet been elucidated , it has been estimated from MERS and SARS that the virus replicates in alveolar epithelial ++\u001b[34mcells\u001b[0m++ , causing lung damage and simultaneously infecting alveolar macrophages .\n",
      "-----------------------------------\n",
      "It has been shown that COVID-19 binds to angiotensin-converting enzyme **\u001b[31m2\u001b[0m** receptors ( ACE2r ) to invade human lung epithelial ++\u001b[34mcells\u001b[0m++ and to initiate the infection .\n",
      "-----------------------------------\n",
      " **\u001b[31mSARS-CoV-2\u001b[0m** can infect ++\u001b[34mcells\u001b[0m++ via the angiotensin-converting enzyme 2 ( ACE2 ) receptor which is ubiquitous but largely expressed in endothelial cells [ 10 ] .\n",
      "-----------------------------------\n",
      " **\u001b[31mMERS-CoV\u001b[0m** enters ++\u001b[34mcells\u001b[0m++ via a common receptor , the dipeptidyl peptidase-4 , and it infects type I and type II alveolar cells ( 7 ) .\n",
      "-----------------------------------\n",
      "Although both SARS **\u001b[31mCoV2\u001b[0m** and prior SARS-CoV utilize ACE2 receptors to invade ++\u001b[34mrespiratory\u001b[0m++ epithelium , the magnitude of infections caused by SARS-CoV2 is enormous .\n",
      "-----------------------------------\n",
      "\u001b[1m=======================================================\u001b[0m\n"
     ]
    }
   ],
   "source": [
    "main(\"results8.txt\", [-1])"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Accuracy: 17/20"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 503,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\u001b[1mQUERY\u001b[0m:\n",
      "arg1:[e]COVID-19 activates the arg2:ATP $receptor\n",
      "\u001b[1m\n",
      "FIRST SPIKE RESULT\u001b[0m:\n",
      " **\u001b[31mSARS-CoV-2\u001b[0m** uses the angiotensin converting ++\u001b[34menzyme\u001b[0m++ 2 ( ACE2 ) receptor to enter the host and this receptor is highly expressed in both the respiratory and gastrointestinal tract 9 , 10 , 11 .\n",
      "\u001b[1m\n",
      "AUGMENTATION RESULTS:\n",
      "\u001b[0m\n",
      " **\u001b[31mSARS-CoV-2\u001b[0m** enters respiratory epithelial cells by attaching to angiotensin converting enzyme-2 ( ACE-2 ) via S-protein ; ++\u001b[34mACE-2\u001b[0m++ is also a receptor for SARS-CoV-1 [ 27 ] .\n",
      "-----------------------------------\n",
      "Presumably , SARS-CoV infects cells through the S protein , which binds to cell surface receptor-angiotensin-converting ++\u001b[34menzyme\u001b[0m++  **\u001b[31m2\u001b[0m** [ 4 ] .\n",
      "-----------------------------------\n",
      "Human angiotensin-converting enzyme 2 ( ++\u001b[34mACE2\u001b[0m++ ) is a functional receptor hijacked by **\u001b[31mSARS-CoV-2\u001b[0m** for cell entry , similar to SARS-CoV [ 8 , 16 ] .\n",
      "-----------------------------------\n",
      "It is now known that **\u001b[31mSARS-CoV-2\u001b[0m** utilizes the same receptor of SARS-CoV , which is angiotensin converting enzyme II ( ++\u001b[34mACE2\u001b[0m++ ) for viral entry into the host cells [ 5 , 40 ] .\n",
      "-----------------------------------\n",
      "With regard to COVID-19 , it is known that the angiotensin-converting enzyme 2 ( ACE2 ) ++\u001b[34mACE2\u001b[0m++ provides the cell membrane receptor entry point for **\u001b[31mSARS-CoV-2\u001b[0m** .\n",
      "-----------------------------------\n",
      "Similar to severe acute respiratory syndrome-associated coronavirus ( SARS-CoV ) 16 , 17 , the **\u001b[31mSARS-CoV-2\u001b[0m** employs angiotensin-converting enzyme-2 ( ++\u001b[34mACE2\u001b[0m++ ) as a receptor for cellular entry .\n",
      "-----------------------------------\n",
      "Molecularly , like SARS-CoV , the **\u001b[31mSARS-CoV-2\u001b[0m** virus likely uses ++\u001b[34mACE-2\u001b[0m++ as entry receptor , which is highly expressed in the lung and gastrointestinal tract [ 10 ] [ 11 ] [ 12 ] .\n",
      "-----------------------------------\n",
      "Studies have demonstrated that **\u001b[31mSARS-CoV-2\u001b[0m** , as well as other corona viruses , requires the angiotensin-converting enzyme 2 ( ++\u001b[34mACE2\u001b[0m++ ) for cellular entry [ 20 ] .\n",
      "-----------------------------------\n",
      "It has been confirmed that **\u001b[31mSARS-CoV2\u001b[0m** utilizes angiotensin-converting enzyme 2 ( ++\u001b[34mACE2\u001b[0m++ ) as receptor for viral cell entry .\n",
      "-----------------------------------\n",
      "Similar to SARS-CoV , **\u001b[31mSARS-CoV-2\u001b[0m** exploits angiotensin-converting enzyme 2 ( ++\u001b[34mACE2\u001b[0m++ ) as a receptor to invade cells , notably type II alveolar epithelial cells .\n",
      "-----------------------------------\n",
      "Like SARS-CoV , 2019-nCoV may use angiotensin-converting enzyme **\u001b[31m2\u001b[0m** ( ++\u001b[34mACE2\u001b[0m++ ) as a potential receptor for host cell infectivity [ 17 ] .\n",
      "-----------------------------------\n",
      "Similar to the SARS-CoV virus implicated in the 2003 SARS outbreak , **\u001b[31mSARS-CoV-2\u001b[0m** facilitates cell entry by attaching to angiotensin converting enzyme 2 ( ++\u001b[34mACE2\u001b[0m++ ) located on the cell surface [ 1 ] .\n",
      "-----------------------------------\n",
      "Like a related coronavirus that emerged in 2003 ( Li et al. , 2003 ) , **\u001b[31mSARS-CoV-2\u001b[0m** enters human cells by binding to the extracellular domain of Angiotensin Converting Enzyme 2 ( ++\u001b[34mACE2\u001b[0m++ ) ( Hoffmann et al. , 2020 ; Zhou et al. , 2020 ) .\n",
      "-----------------------------------\n",
      "Like a related coronavirus that emerged in 2003 , **\u001b[31mSARS-CoV-2\u001b[0m** enters human cells by binding to the extracellular domain of Angiotensin Converting Enzyme 2 ( ++\u001b[34mACE2\u001b[0m++ ) [ 14 , 15 ] .\n",
      "-----------------------------------\n",
      " **\u001b[31mSARS-CoV2\u001b[0m** , the virus responsible for COVID-19 , is known to gain entry into cells via the angiotensinconverting enzyme 2 ( ++\u001b[34mACE2\u001b[0m++ ) receptor .\n",
      "-----------------------------------\n",
      "Similar to SARS-CoV , the receptor-binding domain ( RBD ) in the S protein of **\u001b[31mSARS-CoV-2\u001b[0m** binds to human ++\u001b[34mACE2\u001b[0m++ receptor in order to gain access into host cells .\n",
      "-----------------------------------\n",
      "Like SARS-CoV , **\u001b[31mSARS-CoV-2\u001b[0m** binds and downregulates ++\u001b[34mACE2\u001b[0m++ upon cell entry [ 7 ] .\n",
      "-----------------------------------\n",
      "It has been discovered that **\u001b[31mSARS-CoV-2\u001b[0m** initiates the entry into cells by binding to human angiotensin-converting enzyme 2 ( ++\u001b[34mhACE2\u001b[0m++ ) through the receptor binding domain ( RBD ) of its spike glycoprotein .\n",
      "-----------------------------------\n",
      "It has been proven that **\u001b[31mSARS-CoV-2\u001b[0m** uses the angiotensin-converting enzyme 2 ( ++\u001b[34mACE2\u001b[0m++ ) as a viral receptor to enter the target cell [ 5 ] .\n",
      "-----------------------------------\n",
      "It has been shown that for viral entry into the host cell , **\u001b[31mSARS-CoV-2\u001b[0m** utilizes the angiotensin converting enzyme 2 ( ++\u001b[34mACE2\u001b[0m++ ) receptors present on the cells .\n",
      "-----------------------------------\n",
      "The **\u001b[31mSARS-CoV-2\u001b[0m** uses angiotensin-converting enzyme 2 ( ++\u001b[34mACE2\u001b[0m++ ) as the receptor for entry into host cells .\n",
      "-----------------------------------\n",
      "\u001b[1m=======================================================\u001b[0m\n"
     ]
    }
   ],
   "source": [
    "main(\"results9.txt\", [-1])"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Accuracy: 19/20"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 502,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\u001b[1mQUERY\u001b[0m:\n",
      "low blood oxygen arg1:levels are a $risk factor in arg2:[e]COVID-19 infection\n",
      "\u001b[1m\n",
      "FIRST SPIKE RESULT\u001b[0m:\n",
      "Among all univariable parameters , **\u001b[31mAPACHE\u001b[0m** II , SOFA , lymphocytes , CRP , LDH , AST , cTnI , BNP , et al were significantly independent risk factors of ++\u001b[34mCOVID-19\u001b[0m++ severity .\n",
      "\u001b[1m\n",
      "AUGMENTATION RESULTS:\n",
      "\u001b[0m\n",
      "Similar to other studies ï¼ our data indicated senior and hypertension are the high risk factors for severe ++\u001b[34mCOVID-19\u001b[0m++  **\u001b[31minfection\u001b[0m** .\n",
      "-----------------------------------\n",
      "These findings suggested that **\u001b[31mmen\u001b[0m** with severe ++\u001b[34mCOVID-19\u001b[0m++ is susceptible to secondary infections with virus or bacteria , resulting in higher utilization rate of advanced antiviral therapy and antibiotics .\n",
      "-----------------------------------\n",
      "In this study , preceding RVIs was one of the independent risk factors associated with severe ++\u001b[34mpneumococcal\u001b[0m++  **\u001b[31mpneumonia\u001b[0m** ( a higher PSI score â¥91 ) , suggesting a potential role of preceding RVIs on clinical severity .\n",
      "-----------------------------------\n",
      "Our study also identified that **\u001b[31mCVD\u001b[0m** is an independent risk factor associated with the progression of ++\u001b[34mCOVID-19\u001b[0m++ to a critical illness at the early stage .\n",
      "-----------------------------------\n",
      "Our findings suggested that , similar with other severe acute respiratory outbreaks , **\u001b[31mcomorbidities\u001b[0m** such as COPD , diabetes , hypertension and malignancy predisposed to adverse clinical outcomes in patients with ++\u001b[34mCovid-19\u001b[0m++ .\n",
      "-----------------------------------\n",
      "Additionally , our study identified that **\u001b[31mage\u001b[0m** is a risk factor for the development of ARDS or death in critically ill patients with ++\u001b[34mCOVID-19\u001b[0m++ .\n",
      "-----------------------------------\n",
      "According to previous reports , male gender , presence of older siblings , tobacco smoke exposure , and siblings attending daycare center were important risk factors for ++\u001b[34mRSV\u001b[0m++  **\u001b[31minfection\u001b[0m** .\n",
      "-----------------------------------\n",
      "Older age , higher CCI scores , smoker , ulcer disease , and previous pneumonia history increased the risk of POP ++\u001b[34mdevelopment\u001b[0m++ in cancer **\u001b[31mpatients\u001b[0m** .\n",
      "-----------------------------------\n",
      "In contrast , frequency of pregnant women among those of reproductive age hospitalized with severe manifestation of influenza A ++\u001b[34m(H1N1)pdm09\u001b[0m++ was high , suggesting that **\u001b[31mpregnancy\u001b[0m** could be associated with development of SARI .\n",
      "-----------------------------------\n",
      "Further , **\u001b[31mage\u001b[0m** was an independent predictor of adverse outcome and discriminator of severe/critical illness , which suggested that old people are more vulnerable to ++\u001b[34mSARS-CoV-2\u001b[0m++ and more likely to develop severe/critical disease .\n",
      "-----------------------------------\n",
      "We demonstrated that some underlying co-morbidities ( **\u001b[31mDM\u001b[0m** , hypertension , and CKD , but not IHD ) , high BMI and male gender were associated with a higher susceptibility of contracting ++\u001b[34mSARS-CoV-2\u001b[0m++ infection .\n",
      "-----------------------------------\n",
      "In line with the previous findings , the ++\u001b[34mSARS-CoV-2\u001b[0m++  **\u001b[31minfection\u001b[0m** showed a clustering onset , a higher likelihood of affecting older males with comorbidities , and the possibility of resulting in severe and even fatal respiratory diseases such as ARDS .\n",
      "-----------------------------------\n",
      " **\u001b[31mOverweight\u001b[0m** and obesity may be independent risk factors of more severe ++\u001b[34mCOVID-19\u001b[0m++ , as well as severe pneumonia during hospitalization due to COVID-19 .\n",
      "-----------------------------------\n",
      "In soldiers with HAdV infection in Korea , ++\u001b[34mHAdV-55\u001b[0m++ was the most prevalent type and might be associated with severe **\u001b[31mclinical\u001b[0m** outcomes .\n",
      "-----------------------------------\n",
      "In soldiers with HAdV infection in Korea , ++\u001b[34mHAdV-55\u001b[0m++ was the most prevalent type and might be associated with severe **\u001b[31mclinical\u001b[0m** outcomes .\n",
      "-----------------------------------\n",
      "Furthermore , **\u001b[31munderlying\u001b[0m** comorbidities such as diabetes mellitus , renal insufficiency , chronic obstructive pulmonary disease ( COPD ) , and malignancy were significant risk factors for developing an Acinetobacter ++\u001b[34minfection\u001b[0m++ .\n",
      "-----------------------------------\n",
      "Our results suggest that male **\u001b[31mpatients\u001b[0m** , delayed admission to hospital after illness onset , and invasive mechanical ventilation during hospitalization were associated with prolonged ++\u001b[34mSARS-CoV-2\u001b[0m++ RNA shedding .\n",
      "-----------------------------------\n",
      "In conclusion , in this study , we found that the clinical factors of age older than 50 years , comorbidities , dyspnea , chest pain , cough , expectoration , decreased lymphocytes , and increased inflammation indicators may be risk factors for severe/critical ++\u001b[34mCOVID-19\u001b[0m++  **\u001b[31mpneumonia\u001b[0m** .\n",
      "-----------------------------------\n",
      "Our retrospective cohort study from the Japanese sepsis registry revealed that **\u001b[31madmission\u001b[0m** route , severity , and infection site could be risk modifiers for ARDS ++\u001b[34min\u001b[0m++ patients with non-pulmonary sepsis .\n",
      "-----------------------------------\n",
      "Based on our meta-analysis , **\u001b[31mhypertension\u001b[0m** was shown to be associated with increased composite poor outcome that consists of mortality , severe ++\u001b[34mCOVID-19\u001b[0m++ , ARDS , need for ICU care and disease progression in patients with COVID-19 .\n",
      "-----------------------------------\n",
      "Our study demonstrated that high level of peripheral blood cytokine IL-6 , CRP and the existence of hypertension were independent risk factors for assessing the **\u001b[31mseverity\u001b[0m** of ++\u001b[34mCOVID-19\u001b[0m++ .\n",
      "-----------------------------------\n",
      "\u001b[1m=======================================================\u001b[0m\n"
     ]
    }
   ],
   "source": [
    "main(\"results10.txt\", [-1])"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Accuarrcy: 12/20"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.7.5"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 4
}
